Background: Acute heart failure (AHF) is a life-threatening condition that necessitates urgent evaluation and treatment with an urgent need for hospital admission. Among the available imaging modalities, echocardiogra...Background: Acute heart failure (AHF) is a life-threatening condition that necessitates urgent evaluation and treatment with an urgent need for hospital admission. Among the available imaging modalities, echocardiography is the method of choice due to its feasibility and cost-effectiveness. Lung ultrasonography in emergency department, critical and cardiac care units is becoming popular. The present study aimed to assess the value of the focused echocardiography and lung ultrasound protocol for guiding treatment and its effect on the hospitalization period in AHF patients admitted to the CCU, 6 months re-hospitalization and mortality. Methods: This study included 40 consecutive patients admitted to the Cardiology and Angiology department after disposition from the emergency department at Alexandria main university hospital in Egypt with the diagnosis of (AHF). Patients were divided into 2 groups, 20 patients received the standard treatment while the other group received a modification of medication doses according to daily imaging changes. All patients were followed up for 6 months to assess the 6 months HF rehospitalization and death rates. Results: Group II patients had a significantly shorter duration of hospitalization;6.45 ± 2.01 days compared to 9.10 ± 3.82 days among group I patients (P = 0.02). There was no significant difference between the two groups regarding the 6 months rehospitalization and death rates. Conclusion: The focused echocardiography and lung ultrasound-guided therapy for AHF patients resulted in a shorter duration of hospitalization without increased adverse events.展开更多
Background: Right ventricular (RV) dysfunction could develop during exercise in</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">pati...Background: Right ventricular (RV) dysfunction could develop during exercise in</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">patients with both hypertension and left ventricular diastolic dysfunction and may contribute to the patient symptoms. The objective is to assess RV function, both at rest and during exercise in patients with hypertension and left ventricular diastolic dysfunction. Methods: We included 30 patients with hypertension and resting LV diastolic dysfunction. The systolic function of the right ventricle was assessed by TAPSE (Tricuspid Annular Plane Systolic Excursion) and S</span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> while E/A ratio, annular lateral E’, E/E’ and E’/A’ were used to measure diastolic function. The global function of the right ventricle was assessed by measuring the right indexed myocardial performance. The dimensions and pulmonary pressures were also measured. Results: The following parameters of RV systolic function were increased significantly with exercise: TAPSE (P = 0.0054), S’ (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">= 0.0045). Moreover, the following diastolic parameters of the RV increased significantly with exercise: E/E’ (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.05), A’</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">(P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.04). The global RV function showed also a significant increase (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.0011). The three RV dimensions as well as the pulmonary artery pressures also increased during exercise (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">= 0.000004, 0.001, and 0.00000064 respectively). In addition, the presence of resting LV grade II DD predicted significantly higher pulmonary pressures during exercise (</span><span style="font-family:Verdana;">P</span><span style="font-family:Verdana;"> =</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.006). The advanced resting grade of LVDD predicted significantly the presence of advanced grade of RVDD with exercise (</span><span style="font-family:Verdana;">P</span><span style="font-family:Verdana;"> =</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.037). Conclusions: Some patients who have both hypertension and LV diastolic dysfunction showed structural and functional changes of the right ventricle at rest. However, all patients had RV functional changes during exercise.展开更多
<strong><span style="font-family:Verdana;">Background:</span></strong> <span style="white-space:normal;font-family:Verdana;" "="">Pulmonary vein isolati...<strong><span style="font-family:Verdana;">Background:</span></strong> <span style="white-space:normal;font-family:Verdana;" "="">Pulmonary vein isolation by means of cryoballoon is a well-es</span><span style="white-space:normal;font-family:Verdana;" "="">tablished way of treatment of atrial fibrillation. The aim of the study was to compare the acute cryoballoon biophysical parameters attained during energy applications to </span><span style="white-space:normal;font-family:Verdana;" "="">the </span><span style="white-space:normal;font-family:Verdana;" "="">individual pulmonary vein during sinus rhythm versus</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;"> atrial fibrillation. </span><b><span style="font-family:Verdana;">Methods: </span></b><span style="font-family:Verdana;">100 </span><b></b><span style="font-family:Verdana;">Patients who underwent their first</span></span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:Verdana;" "="">time PVI using second</span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;">generation cryoballoon for symptomatic and drug-refractory AF, between the beginning of March to end of August 2016, were initially screened. 61 patients with paroxysmal AF were included in the present study. 39 patients with persistent AF were excluded. No pre-procedural anatomical imaging was reported. </span><b><span style="font-family:Verdana;">Results</span></b><span style="font-family:Verdana;">: A total of 61 patients (male 80%, age 59.3</span></span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">± 13.4 years) </span><span style="white-space:normal;font-family:Verdana;" "="">were included in the present analysis. </span><span style="white-space:normal;font-family:Verdana;" "="">A </span><span style="white-space:normal;font-family:Verdana;" "="">total of 243 pulmonary veins were </span><span style="white-space:normal;font-family:Verdana;" "="">isolated with an average of 1.87</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">± 1.14 cryo</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">energy applications per individual vein. During cryo application, there were no significant difference</span><span style="white-space:normal;font-family:Verdana;" "="">s</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;"> between applications delivered during sinus rhythm or ongoing AF in the rate of temperature drop at 5 and 30 s, rate of warming at 5 s after freezing stop or achieved balloon nadir temperature. The same also was observed for both the balloon cooling rate and warming times. </span><b><span style="font-family:Verdana;">Conclusions: </span></b><span style="font-family:Verdana;">The present analysis shows no impact of the patient baseline rhythm at the time of energy application upon the acute balloon biophysical parameters in patients with normal sinus rhythm and those with ongoing atrial fibrillation using the second</span></span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:Verdana;" "="">generation cryo</span><span style="white-space:normal;font-family:Verdana;" "="">balloon.</span>展开更多
<strong>Background:</strong><span style="white-space:normal;font-size:10pt;font-family:;" "=""><strong> </strong>Arrhythmias after acute myocardial infarctio...<strong>Background:</strong><span style="white-space:normal;font-size:10pt;font-family:;" "=""><strong> </strong>Arrhythmias after acute myocardial infarction are common. Bra</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">dyarrhythmias need specific insight into when and how to treat them. <b>Objective</b></span><b style="white-space:normal;"><span style="font-size:10pt;font-family:;" "="">s</span><span style="font-size:10pt;font-family:;" "="">: </span></b><span style="white-space:normal;font-size:10pt;font-family:;" "="">To delineate the incidence, course, and management of different types of</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">bradyarrhythmia</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">s</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> after acute myocardial infarction, </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">the </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">study period was five years. <b>Methods: </b>453 patients with Acute Myocardial Infarction (AMI) were admitted to intensive care in five years. ECGs were analyzed for the presence of bra</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">dyarrhythmias and details of management. <b>Results: </b>65 patients with bradycardia were found. Sinus bradycardia </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 40, sick sinus syndrome </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, junctional rhy</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">thm </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, second-degree block</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, complete heart block </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 24. We divided patients with sinus bradycardia into </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">a </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">stable </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">group </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">and </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">an </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">unstable</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> group</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">. Unstable sinus bradycardia is more prevalent in cases with hypotension or shock, slower heart rates, gross or transmural infarction</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">.</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> Also</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">,</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> predictors of instability were ch</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">angeable morphology of the </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">“</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">P</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">”</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> wave and inferior rather than anterior infarction</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">.</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">The indications and danger of atropine are defined. Complete heart block was found in 24 patients (0.053%). 13 were managed by drug therapy (isoprenaline, corticosteroids, and atropine);</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">Eleven patients were paced</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">. 14 out of the 24 patients died (58%), the total mortality rate among the 453 patients was 22%. The</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> prognostic factors of CHB were defined. Techniques of introduc</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">tion of the</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> lead in RV without fluoroscopy are described. <b>Conclusions:</b> Sinus bradycardia in AMI is accompanied by a lower incidence of mortality. Atropine is not a safe drug to be given as routine. Complete heart block predictors of mortality are the association with heart failure, early-onset, and persistence of the block.</span>展开更多
文摘Background: Acute heart failure (AHF) is a life-threatening condition that necessitates urgent evaluation and treatment with an urgent need for hospital admission. Among the available imaging modalities, echocardiography is the method of choice due to its feasibility and cost-effectiveness. Lung ultrasonography in emergency department, critical and cardiac care units is becoming popular. The present study aimed to assess the value of the focused echocardiography and lung ultrasound protocol for guiding treatment and its effect on the hospitalization period in AHF patients admitted to the CCU, 6 months re-hospitalization and mortality. Methods: This study included 40 consecutive patients admitted to the Cardiology and Angiology department after disposition from the emergency department at Alexandria main university hospital in Egypt with the diagnosis of (AHF). Patients were divided into 2 groups, 20 patients received the standard treatment while the other group received a modification of medication doses according to daily imaging changes. All patients were followed up for 6 months to assess the 6 months HF rehospitalization and death rates. Results: Group II patients had a significantly shorter duration of hospitalization;6.45 ± 2.01 days compared to 9.10 ± 3.82 days among group I patients (P = 0.02). There was no significant difference between the two groups regarding the 6 months rehospitalization and death rates. Conclusion: The focused echocardiography and lung ultrasound-guided therapy for AHF patients resulted in a shorter duration of hospitalization without increased adverse events.
文摘Background: Right ventricular (RV) dysfunction could develop during exercise in</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">patients with both hypertension and left ventricular diastolic dysfunction and may contribute to the patient symptoms. The objective is to assess RV function, both at rest and during exercise in patients with hypertension and left ventricular diastolic dysfunction. Methods: We included 30 patients with hypertension and resting LV diastolic dysfunction. The systolic function of the right ventricle was assessed by TAPSE (Tricuspid Annular Plane Systolic Excursion) and S</span><span style="font-family:Verdana;">,</span><span style="font-family:Verdana;"> while E/A ratio, annular lateral E’, E/E’ and E’/A’ were used to measure diastolic function. The global function of the right ventricle was assessed by measuring the right indexed myocardial performance. The dimensions and pulmonary pressures were also measured. Results: The following parameters of RV systolic function were increased significantly with exercise: TAPSE (P = 0.0054), S’ (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">= 0.0045). Moreover, the following diastolic parameters of the RV increased significantly with exercise: E/E’ (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.05), A’</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">(P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.04). The global RV function showed also a significant increase (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">=</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.0011). The three RV dimensions as well as the pulmonary artery pressures also increased during exercise (P</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">= 0.000004, 0.001, and 0.00000064 respectively). In addition, the presence of resting LV grade II DD predicted significantly higher pulmonary pressures during exercise (</span><span style="font-family:Verdana;">P</span><span style="font-family:Verdana;"> =</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.006). The advanced resting grade of LVDD predicted significantly the presence of advanced grade of RVDD with exercise (</span><span style="font-family:Verdana;">P</span><span style="font-family:Verdana;"> =</span><span style="font-family:Verdana;"> </span><span style="font-family:Verdana;">0.037). Conclusions: Some patients who have both hypertension and LV diastolic dysfunction showed structural and functional changes of the right ventricle at rest. However, all patients had RV functional changes during exercise.
文摘<strong><span style="font-family:Verdana;">Background:</span></strong> <span style="white-space:normal;font-family:Verdana;" "="">Pulmonary vein isolation by means of cryoballoon is a well-es</span><span style="white-space:normal;font-family:Verdana;" "="">tablished way of treatment of atrial fibrillation. The aim of the study was to compare the acute cryoballoon biophysical parameters attained during energy applications to </span><span style="white-space:normal;font-family:Verdana;" "="">the </span><span style="white-space:normal;font-family:Verdana;" "="">individual pulmonary vein during sinus rhythm versus</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;"> atrial fibrillation. </span><b><span style="font-family:Verdana;">Methods: </span></b><span style="font-family:Verdana;">100 </span><b></b><span style="font-family:Verdana;">Patients who underwent their first</span></span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:Verdana;" "="">time PVI using second</span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;">generation cryoballoon for symptomatic and drug-refractory AF, between the beginning of March to end of August 2016, were initially screened. 61 patients with paroxysmal AF were included in the present study. 39 patients with persistent AF were excluded. No pre-procedural anatomical imaging was reported. </span><b><span style="font-family:Verdana;">Results</span></b><span style="font-family:Verdana;">: A total of 61 patients (male 80%, age 59.3</span></span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">± 13.4 years) </span><span style="white-space:normal;font-family:Verdana;" "="">were included in the present analysis. </span><span style="white-space:normal;font-family:Verdana;" "="">A </span><span style="white-space:normal;font-family:Verdana;" "="">total of 243 pulmonary veins were </span><span style="white-space:normal;font-family:Verdana;" "="">isolated with an average of 1.87</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">± 1.14 cryo</span><span style="white-space:normal;font-family:;" "=""> </span><span style="white-space:normal;font-family:Verdana;" "="">energy applications per individual vein. During cryo application, there were no significant difference</span><span style="white-space:normal;font-family:Verdana;" "="">s</span><span style="white-space:normal;font-family:;" "=""><span style="font-family:Verdana;"> between applications delivered during sinus rhythm or ongoing AF in the rate of temperature drop at 5 and 30 s, rate of warming at 5 s after freezing stop or achieved balloon nadir temperature. The same also was observed for both the balloon cooling rate and warming times. </span><b><span style="font-family:Verdana;">Conclusions: </span></b><span style="font-family:Verdana;">The present analysis shows no impact of the patient baseline rhythm at the time of energy application upon the acute balloon biophysical parameters in patients with normal sinus rhythm and those with ongoing atrial fibrillation using the second</span></span><span style="white-space:normal;font-family:Verdana;" "="">-</span><span style="white-space:normal;font-family:Verdana;" "="">generation cryo</span><span style="white-space:normal;font-family:Verdana;" "="">balloon.</span>
文摘<strong>Background:</strong><span style="white-space:normal;font-size:10pt;font-family:;" "=""><strong> </strong>Arrhythmias after acute myocardial infarction are common. Bra</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">dyarrhythmias need specific insight into when and how to treat them. <b>Objective</b></span><b style="white-space:normal;"><span style="font-size:10pt;font-family:;" "="">s</span><span style="font-size:10pt;font-family:;" "="">: </span></b><span style="white-space:normal;font-size:10pt;font-family:;" "="">To delineate the incidence, course, and management of different types of</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">bradyarrhythmia</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">s</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> after acute myocardial infarction, </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">the </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">study period was five years. <b>Methods: </b>453 patients with Acute Myocardial Infarction (AMI) were admitted to intensive care in five years. ECGs were analyzed for the presence of bra</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">dyarrhythmias and details of management. <b>Results: </b>65 patients with bradycardia were found. Sinus bradycardia </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 40, sick sinus syndrome </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, junctional rhy</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">thm </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, second-degree block</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 10, complete heart block </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">in</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> 24. We divided patients with sinus bradycardia into </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">a </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">stable </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">group </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">and </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">an </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">unstable</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> group</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">. Unstable sinus bradycardia is more prevalent in cases with hypotension or shock, slower heart rates, gross or transmural infarction</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">.</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> Also</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">,</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> predictors of instability were ch</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">angeable morphology of the </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">“</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">P</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">”</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> wave and inferior rather than anterior infarction</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">.</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> </span><span style="white-space:normal;font-size:10pt;font-family:;" "="">The indications and danger of atropine are defined. Complete heart block was found in 24 patients (0.053%). 13 were managed by drug therapy (isoprenaline, corticosteroids, and atropine);</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">Eleven patients were paced</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">. 14 out of the 24 patients died (58%), the total mortality rate among the 453 patients was 22%. The</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> prognostic factors of CHB were defined. Techniques of introduc</span><span style="white-space:normal;font-size:10pt;font-family:;" "="">tion of the</span><span style="white-space:normal;font-size:10pt;font-family:;" "=""> lead in RV without fluoroscopy are described. <b>Conclusions:</b> Sinus bradycardia in AMI is accompanied by a lower incidence of mortality. Atropine is not a safe drug to be given as routine. Complete heart block predictors of mortality are the association with heart failure, early-onset, and persistence of the block.</span>